These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8612118)

  • 1. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection.
    Belchi-Hernandez J; Espinosa-Parra FJ
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome.
    Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S.
    Yoshizawa S; Yasuoka A; Kikuchi Y; Honda M; Gatanaga H; Tachikawa N; Hirabayashi Y; Oka S
    Ann Allergy Asthma Immunol; 2000 Sep; 85(3):241-4. PubMed ID: 11030281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.
    Roudier C; Caumes E; Rogeaux O; Bricaire F; Gentilini M
    Arch Dermatol; 1994 Nov; 130(11):1383-6. PubMed ID: 7979438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons.
    Rich JD; Sullivan T; Greineder D; Kazanjian PH
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):409-14. PubMed ID: 9396972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
    Jung AC; Paauw DS
    Arch Intern Med; 1994 Nov; 154(21):2402-6. PubMed ID: 7979835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
    Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection.
    Wormser GP; Horowitz HW; Duncanson FP; Forseter G; Javaly K; Alampur SK; Gilroy SA; Lenox T; Rappaport A; Nadelman RB
    Arch Intern Med; 1991 Apr; 151(4):688-92. PubMed ID: 1901482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
    Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
    Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection].
    Piketty C; Gilqouin J; Kazatchkine M
    Ann Med Interne (Paris); 1996; 147(5):327-30. PubMed ID: 9033734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature.
    Ryan C; Madalon M; Wortham DW; Graziano FM
    WMJ; 1998 May; 97(5):23-7. PubMed ID: 9617304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.
    White MV; Haddad ZH; Brunner E; Sainz C
    Ann Allergy; 1989 Mar; 62(3):177-9. PubMed ID: 2522290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
    Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
    J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse reactions to trimethoprim-sulfamethoxazole in AIDS patients].
    Irazábal B; Camino E; Cid de Rivera C; Aguirrebengoa K; Urkijo JC
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):429-32. PubMed ID: 8260515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMP-SMX desensitization.
    Posit Aware; 1995; ():7. PubMed ID: 11362574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection.
    Anders HJ; Bogner JR; Goebel FD
    Eur J Med Res; 1997 May; 2(5):198-200. PubMed ID: 9153343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
    Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR;
    J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
    Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
    Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO
    Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.